Infinite Clinical Research

Infinite Clinical Research (ICR) is a premier full-service contract research organization (CRO) headquartered in Mexico City, Mexico. Founded in 2002 by Arturo Rodriguez Jacob, the company provides comprehensive clinical development, regulatory affairs, and pharmacovigilance services across Latin America, including Argentina, Brazil, Chile, and Colombia. ICR is a founding member of the Mexican Association of CROs (ACROM) and is recognized for its deep expertise in navigating the COFEPRIS regulatory environment. While primarily a service provider for global pharmaceutical and biotechnology companies, the firm has also engaged in proprietary research, notably holding patents for multi-drug combinations in the treatment of Type 2 diabetes.